Predictive Utility of Patient Reported Outcomes for Survival in 1st-Line Treated Patients with a NSCLC in EMPOWER-Lung 1 and 3

Gandara, D. R.Gogishvili, M.Sezer, A.Makharadze, T.Guemues, M.McIntyre, D. A.He, X.Yan, E.Gullo, G.Rietschel, P.Quek, R. G.2024-04-242024-04-2420231556-0864http://hdl.handle.net/11727/12037enginfo:eu-repo/semantics/closedAccessCemiplimabAdvanced non-small cell lung cancerPatientreported outcomesPredictive Utility of Patient Reported Outcomes for Survival in 1st-Line Treated Patients with a NSCLC in EMPOWER-Lung 1 and 3Conference Object1811S117S1170010988316001431556-1380